Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q1 CY2025 results , with sales up 28.8% year on year to ...

PODD’s total return over the past decade averaged ... Note that holding non-UK shares carries an element of foreign exchange risk. For example, if the pound strengthens against the dollar ...

The ‘Multi-Talent’ uses standard 5 mm NMR samples and includes gradient spectroscopy with options for adjustable sample temperature ... s 16.5% growth. PODD’s earnings beat estimates in ...

Wall Street analysts forecast that Insulet (PODD) will report quarterly earnings of $0.81 per share in its upcoming release, pointing to a year-over-year increase of 11%. It is anticipated that ...

Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our Twin Momentum Investor model based on the published strategy ...

The S&P 500 has rallied sharply since April lows, but investors should be prepared for the gains to fade as more trade deals ...

Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of ...

7 analysts have shared their evaluations of Insulet PODD during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...

The well-known market adage "Sell in May and Go Away" advises investors to exit equity markets during a historically underperforming six-month period beginning in May. However, for 2025, many market ...